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The gene for solute carrier family 12 member A8 has recently been proposed as a candidate gene for psoriasis
susceptibility (PSORS5) on chromosome 3q based on association of ﬁve single nucleotide polymorphisms (SNP) in
Swedish patients. To investigate whether this locus is relevant for German psoriasis vulgaris (PsV) patients, we
analyzed a group of 210 trios and a case–control group including 375 patients. Based on our investigation of the
linkage disequilibrium (LD) structure of SLC12A8, we assayed 35 haplotype tag SNP and grouped them into nine
LD-blocks. In the case–control study, we detected an association for six SNP and three LD-based haplotypes.
Association was strongest for ss35527511 (v2¼ 11.224, p¼ 0.0008) and haplotype E-2 (v2¼ 11.788, p¼ 0.00059)
and independent of the presence of an HLA-associated PSORS1 risk allele. Through extended haplotype analysis,
we could show that two independent association signals exist in SLC12A8, suggesting allelic heterogeneity. None
of the SNP showed association in trios, apart from a weak association of rs2228674 (transmission disequilibrium
test statistics p¼ 0.048), probably due to insufﬁcient power. We conclude that SLC12A8 is a susceptibility locus
for PsV. In order to establish the exact nature of this association, efforts to identify the disease-causing variants
are ongoing.
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At chromosome 3q21, (Enlund et al (1999) proposed a can-
didate region showing linkage and association of the mi-
crosatellite D3S1551 to psoriasis after stratification of their
sample for parental origin (at least one parent originating
from Southwest Sweden). The following linkage disequilib-
rium mapping of the candidate region on 3q21 identified
SLC12A8 as a candidate gene based on association of
psoriasis to several intronic single nucleotide polymorph-
isms (SNPs) as well as to haplotypes (Hewett et al, 2002).
It has long been known that in general, SNPs show
stronger linkage disequilibrium (LD) the closer they are lo-
cated, although this relation can be erratic in many cases.
Some distant SNPs can show strong LD, whereas close
ones show almost none. Since the first publications of Re-
ich et al (2001) and Daly et al (2001), it has been recognized
that the genome consists of haplotype blocks characterized
by few or no recombinations; therefore, SNPs within the
same haplotype block are in strong LD. The haplotype
blocks are confined by recombination hot spots with little
or no LD. Only few different haplotypes within one block
account for the majority of detected haplotypes. The
haplotype diversity can be ascertained by genotyping ha-
plotype tag SNPs (htSNPs) (Johnson et al, 2001), whose
combination represents the (majority of) detected haplo-
types within a haplotype block. Due to the consistency of
these haplotype blocks during the last millennia, it is being
recognized that it might be a more advantageous approach
to characterize the block structure of a candidate region
and to use this information for association studies instead of
single SNPs for defining genetic variants underlying com-
mon complex diseases.
We set out to replicate the finding of Hewett et al (2002)
in our psoriasis samples of 375 psoriasis vulgaris (PsV) pa-
tients and of 210 trios of German origin. In order to sys-
tematically investigate this locus, we determined the LD-
based haplotype block structure of SLC12A8 and tested
single SNP as well as haplotypes within the block structure
for allelic association in both study groups. In order to deter-
mine whether the association with SLC12A8 was independ-
ent of the major psoriasis susceptibility locus (PSORS1),
which is linked to the MHC locus, we stratified for the risk
allele at this locus and tested again for association.
Results
SNP identiﬁcation and genotyping A total of 102 SNP
with minor allele frequency (MAF)40.1 were identified by
Abbreviations: HCR, alpha-helix coiled-coil rod homolog gene;
htSNP, haplotype tag SNP; LD, linkage disequilibrium; MAF, minor
allele frequency; PSORS5, gene for psoriasis susceptibility; PsV,
psoriasis vulgaris; SNP, single nucleotide polymorphism; TDT,
transmission disequilibrium test
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direct sequencing of the 71 amplicons described above.
From these, the 68 SNPs showing MAF40.2 in the 24 pa-
tients sequenced were included in the study, leading to an
average density of one SNPs every 3 kb (Table S3). The only
coding SNP identified is rs2981482, located in exon 14,
and leading to an aminoacid change from arginine to gluta-
mine (R664Q); the remainder were located in introns or in
untranslated regions (UTR). After reconstruction of haplo-
types in the whole region with PHASE (Stephens et al,
2001), SNPtagger (Ke and Cardon, 2003) was used to de-
termine the 35 tag SNPs that were subsequently genotyped
in the cohorts. The average genotyping rate was 98.1%.
Hardy–Weinberg equilibrium for all tag SNPs was confirmed
in all cohorts.
Association with single SNPs The case–control study
provided association with six SNPs, with ss35527511 show-
ing the strongest association (w2¼11.224, p¼0.0008, odds
ratio (OR)¼1.51 [1.19–1.92]) (Table I). Two of the tag SNPs,
ss35527511 and rs651630, remained significant even after
Bonferroni correction for multiple testing (e.g., ss35527511
pc¼0.028; 35 SNPs tested), which is overly conservative
and known to overcorrect data (Cardon and Bell, 2001). A
complete overview of the association with single SNPs in
the case–control study is presented in Fig 1. In the trios with
PsV, single SNP analysis resulted in only a marginal signif-
icant transmission disequilibrium test (TDT) p-value of 0.048
for rs2228674 (EC2 (Hewett et al, 2002)).
Haplotype block structure of SLC12A8 The 68 SNPs with
MAF40.2 sequenced in 24 probands were used to deter-
mine the haplotype block structure of SLC12A8. A total of
nine haplotype blocks between 3 and 20 kb long were
identified (Fig 2). Using the 35 tag SNPs genotyped in the
case–control samples, this haplotype block structure was
confirmed in the two groups (375 PsV patients and 376
controls) (data not shown).
Association with haplotype blocks Data for associated
haplotypes in the case–control study are shown in Table II,
and Fig 3 summarizes the results for all haplotype blocks in
this study group. Strong association with haplotypes in
block B and block E was observed. Haplotype B-2
(w2¼ 10.552, p¼0.001, OR¼1.41 [1.15–1.73]) as well as
haplotype E-1 (w2¼8.821, p¼0.003, OR¼1.40 [1.130–
1.75]) were the risk haplotypes. One further haplotype, A-5,
was also strongly associated (w2¼10.202, p¼0.001,
OR¼2.27 [1.36–3.80]), whereas it accounted for only a mi-
nor number of 6% of haplotypes in patients and 3% in
controls. Two other adjacent haplotypes, A-3 and H-3, were
also slightly associated. The PsV trios were not tested for
association at the haplotype level.
Analysis of long-range haplotypes We next investigated
whether the haplotype blocks associated are part of the
same long-range haplotype and whether we could clarify the
localization of the association signal. We used Haploview
Table I. Allele frequencies of the associated tag SNP in patients and controls and results of v2 statistics
SNP rs/ss-number
Controls
Psoriasis vulgaris
n (%) n (%) v2 p-value OR [95% conﬁdence interval]
ss35527513
Allele A 605 (81) 636 (86) 8.164 0.0043 1.50 [1.14–1.98]
Allele T 145 (19) 102 (14)
ss35527511
Allele A 205 (27) 149 (20) 11.224 0.0008 1.51 [1.19–1.92]
Allele G 543 (73) 595 (80)
rs9813946
Allele A 489 (65) 528 (71) 6.505 0.011 1.33 [1.07–1.65]
Allele C 261 (35) 212 (29)
rs9831295
Allele A 500 (69) 551 (74) 5.267 0.022 1.31 [1.04–1.64]
Allele G 224 (31) 189 (26)
rs1554241
Allele A 265 (36) 305 (41) 3.889 0.049 1.24 [1.00–1.52]
Allele T 471 (64) 439 (59)
rs651630
Allele A 423 (57) 354 (48) 10.97 0.0009 1.40 [1.14–1.72]
Allele G 325 (43) 384 (52)
SNP, single nucleotide polymorphism; OR, odds ratio.
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(Barrett et al, 2005) to reconstruct longer-range haplotypes
from single SNPs between blocks B and E and their adja-
cent regions in the gene (Fig 4). When we included the five
haplotypes of block C in the analysis of the two associated
haplotypes B-2 or E-1, we failed to observe any significant
difference between patients and controls, indicating that the
two signals observed in block B and block E are independ-
ent of each other.
We next included rs1554241 and rs651630, which are
also associated in the case–control study at a single SNP
level, but that are not included in neither of their flanking
blocks E and F nor G and H, respectively, into haplotypes
with haplotype E1. All these haplotypes showed associa-
tion, whereas a haplotype comprising E-1 and rs1712458,
located immediately upstream and not contained in any
block, showed a stronger association than haplotype E-1
alone. When also including rs684030, the tag SNP of ha-
plotype block D, however, the association appeared to be
weaker, indicating that the causative variant is located be-
tween both blocks in a region of low LD. In the proximal part
of the gene, the longer-range haplotype comprising haplo-
types A-5 and B-2 was associated (w2¼11.8, p¼0.0006),
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Figure 1
Results of the v2 statistics for the 35 tag single nucleotide polymorphism in SLC12A8 (compared with controls). The horizontal line indicates
the significance level of po0.05. Curly braces indicate affiliation to a haplotype block.
5´ A B C D E F G H
1 2 3 4 5 6 7 8 9 10 11-1314(a)
(b) 5 A B C D E F G H´
10 kb
Figure 2
Linkage disequilibrium (LD) structure of gen-
omic region including SLC12A8. (a) Exon struc-
ture of SLC12A8. 50 and 30 untranslated regions
are indicated as thinner blocks. Nine haplotype
blocks (50 and from A to H). (b) Pairwise LD plot
for the 68 single nucleotide polymorphism (SNP)
with minor allele frequency (MAF)40.2 in
SLC12A8. Each square plots the level of LD be-
tween a pair of sites in the region; comparisons
between neighboring sites lie along the first line.
Black coloring indicates strong LD, gray indicates
intermediate or uninformative LD, and white indi-
cates weak LD. The areas limited by a black line
show the nine haplotype blocks along the gene
defined as described in Material and Methods.
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even at a higher level than either of the two haplotypes
alone.
Association with SLC12A8 is independent from PSOR-
S1 As expected, we found strong association with the
risk alleles of the two single HCR-SNPs at PSORS1
(4.26  1014 for HCR-325T and 1.15  108 for HCR-
2327G). Deviation from Hardy–Weinberg equilibrium for the
two HCR-SNPs was also detected due to significant excess
of patients heterozygous for the risk alleles. In contrast,
Hardy–Weinberg equilibrium was confirmed in the control
group. We next investigated whether patients of the case–
control study carrying the HCR risk haplotype at PSORS1
had a higher frequency of haplotypes A-5, B-2, E-1, or H-3.
We found no significant differences in the two study groups,
indicating that the risk alleles in LD with haplotypes A5, B-2,
E-1, or H3 do not add any additional risk to that conferred
by the PSORS1 risk haplotype, and thus act independently.
Discussion
Our systematic LD analysis provides the first replication of
association with SLC12A8, a candidate gene for psoriasis at
Table II. Frequencies of the associated haplotypes within a haplotype block in patients and controls and results of v2 statistics
Block-haplotype Allele combination
Controls
Psoriasis vulgaris
n (%) n (%) v2 p-value
OR [95% conﬁdence
interval]
A-3 A G G C A T A 67 (9) 45 (6) 4.607 0.032
A-5 A A A T G T G 22 (3) 48 (6) 10.202 0.001 2.27 [1.36–3.80]
B-2 A A 274 (36) 335 (45) 10.552 0.001 1.41 [1.15–1.73]
B-3 A A 145 (19) 102 (14) 8.823 0.003
E-1 T A C G G A A 197 (26) 249 (33) 8.821 0.003 1.40 [1.13–1.75]
E-2 T A C A G C G 180 (24) 126 (17) 11.788 0.00059
H-3 T A G G 192 (26) 232 (31) 5.407 0.02 1.31 [1.04–1.64]
OR, odds ratio.
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Figure 3
Results of the v2 statistics for the haplotypes within a haplotype block in SLC12A8 (compared with controls). The horizontal line indicates the
significance level of po0.05.
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PSORS5 on 3q21 (Hewett et al, 2002). Of five associated
SNPs in the original study, only two were significant on their
own in our study: rs1554241 (B1551S3, p¼0.049 in the
single cases) and rs2228674 (EC2, TDT p¼0.048 in the tri-
os). In addition, rs531740 (BES2) is part of haplotype E-1,
which is strongly associated in our case–control study. SNP
rs702045 (B1551S4), further reported to be associated in
the Swedish group, was not included in our study due to its
low MAF (0.05).
In the initial report, the five associated variants were re-
ported to form a haplotype that was highly associated with
PsV (p¼3.8  105). Constructing haplotypes without tak-
ing into account the underlying LD structure of a region can
result in a false-positive association due to casual LD be-
tween these markers and the localization of the true causal
SNP some distance away (Daly et al, 2001). Also, the res-
olution of the haplotype block structure of a gene and the
use of the corresponding haplotypes in each block is much
more powerful than marker-by-marker analysis (Zhang et al,
2002). Therefore, we determined the haplotype structure of
SLC12A8 and used these haplotypes to confirm and extend
the association analysis based on single SNPs and to clarify
the localization of the signal. Due to the current awareness
that haplotypes can be better discerned when using an-
cestral SNPs, which are therefore more frequent, we set a
cutoff for SNPs with MAF40.2 based on the initial sample
of probands. Thus, we obtained a block-like structure of
regions with high LD (D040.8) sharply demarcated from re-
gions of low LD (Fig 2). Blocks of high LD varied between 3
and 20 kb, whereas haplotype diversity varied between
three and five different common haplotypes, consistent with
data in the literature (Gabriel et al, 2002).
The number of SNPs required to reliably detect the un-
derlying LD structure is dependent on the overall LD of the
region. The average density in our study with one SNP every
3 kb is much denser than the current HapMap data avail-
able, and allowed us to detect boundaries of critical regions
with association more reliably, as reported previously (Cardon
and Abecasis, 2003). We chose tag SNPs based on the LD
structure in order to ascertain the underlying haplotype var-
iability using various computational tools. This choice of tag
SNPs independent of exact block boundaries has the ad-
vantage of identifying disease association with either spe-
cific haplotypes or with clades of related haplotypes
(Carlson et al, 2004), as neighboring blocks can be corre-
lated (Cardon and Abecasis, 2003) and an etiological variant
may lie inside a recombination hot spot between two ha-
plotype blocks (Kauppi et al, 2004).
By using these tag SNPs for association studies, we de-
tected a total of six SNPs showing significant association in
the case–control study different from those SNPs originally
reported. Two of them (ss35527511 and rs651630) re-
mained significant even after the overly conservative
Bonferroni correction for multiple testing, indicating that
the association is a true finding. The association with single
SNPs was confirmed at haplotype level: two of the three
most significantly associated SNPs are contained in haplo-
type blocks B and E, respectively. The level of association
for block E is similar to that of SNP 34, whereas association
with blocks B and A is remarkably higher than for single
SNP analysis. This effect is well known as haplotypes can
be more informative than single bi-allelic SNPs, when they
are only in LD with the causative variant. The corresponding
OR for the highly associated ss35527511 (OR¼1.51 [1.19–
1.92]) and for haplotype B-2 (OR¼ 1.41 [1.15–1.73]) are in
the expected range for a complex disease such as PsV with
its multiple susceptibility loci.
Next, we tried to unify the association signals seen from
blocks A, B, and E through reconstruction of long-range
haplotypes between these blocks. Although we tried sev-
eral combinations (Fig 4), we failed to observe any asso-
ciation with these longer-range haplotypes, suggesting that
the association signals are independent of each other. If veri-
fied, this would demonstrate allelic heterogeneity in SLC12A8.
This heterogeneity could account for the difficulty that
we and Hewett and co-workers had in finding significant
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Figure 4
Overview of different asso-
ciation levels including long-
er-range haplotypes in the
case–control study. (a) Exon
structure of SLC12A8. 50and 30
untranslated regions are indi-
cated as thinner blocks. (b)
Eight intragenic haplotype
blocks (from A to H), strong-
ly associated haplotypes in
black. (c) Associated single
nucleotide polymorphisms in
case–control study displayed
as black arrows, dashed arrow
indicates rs1712458. (d) Ex-
tension of longer-range haplo-
types and significance levels
of association in the case–
control study (w2 statistics)
(for details, see manuscript).
910 HU¨FFMEIER ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
evidence for association. We assume that the association
reported for the Swedish population corresponds to that
observed for haplotype E-1 in the German patients.
Once an association is found in a case–control study, it is
desirable to confirm it in an independent sample and pref-
erably by using a different study design, e.g., TDT, known to
have less power (Morton and Collins, 1998) but to be more
resistant to possible population stratification (Martin et al,
2000). No association in our group of 210 parent–offspring
trios was detected, only a marginal significant p-value for
SNP 68 (EC2 in Hewett et al, 2002). The power of TDT-
based studies requires significantly more patients to find the
same level of association as case–control studies (Cardon
and Bell, 2001). In order to estimate the sample size of a
TDT study that would have allowed us to find the same level
of association as in our case–control study, we applied the
model of Mitchell (2000). In this model, a T value is calcu-
lated with the results of the case–control study, and is used
to estimate Nmin, the minimum number of informative trans-
missions required in the TDT study to reject the null hy-
pothesis of no linkage. A requirement of a number of
informative trios between 151 and 613 was calculated to
reach a significance level of 0.05 with 80% power (Table
S4). In our study, this figure was only attained for rs651630.
Interestingly, this SNP is highly associated in the single
cases, and is the only one that is close to the significance
level in the TDT study (p¼0.064). We thus conclude,
that our group of trios was underpowered to detect the
association.
It has been previously reported that other psoriasis sus-
ceptibility loci show epistasis to the major psoriasis sus-
ceptibility locus at PSORS1 (Veal et al, 2001). Therefore, we
investigated whether the association with SLC12A8 was
contingent to the presence of the risk allele at PSORS1. We
determined this allele indirectly based on an HCR risk ha-
plotype, which is in very high LD with the common PSORS1
risk allele, a procedure that has been used before (As-
umalahti et al, 2003; Huffmeier et al, 2005). Interestingly, we
detected no difference in allele frequencies independent of
the presence or absence of the risk allele. Thus, we found
no evidence for interaction of this SLC12A8 with PSORS1
and conclude that their effects in the pathogenesis of PsV
are independent of each other.
The exact nature of the disease-causing variants in
SLC12A8 yet remains to be elucidated. The only coding
SNP that we identified (R664Q, rs2981482) did not show
any association and is also in a region with comparably low
association at haplotype level. In the regions showing
stronger association, no further coding variant was identi-
fied. We thus assume that variants affecting regulatory or
splicing processes will be the risk factors at PSORS5. Since
these processes are only partially understood and since the
density of SNP in intronic sequences is much higher than in
coding ones, it will require extensive sequencing efforts in
large numbers of patients as well as functional studies in
order to pinpoint the exact variants.
New questions arise from the still unknown function of
SLC12A8 and its potential role in the pathogenesis of PsV.
Thus, the gene SLC12A8 encodes a protein-sharing ho-
mology with a family of cation-chloride-coupled cotrans-
porters that are responsible for the electroneutral transport
of ions in a variety of different cell types (Delpire and Mount,
2002). Our study provides evidence for involvement of the
member A8 in the pathogenesis of psoriasis. Primarily func-
tional studies are essential to investigate the regular role of
SLC12A8, e.g., the nature of transported substrate(s) as
well as further aspects also regarding the compromised
function in PsV.
In summary, our study replicates the previously de-
scribed association with SLC12A8 at PSORS5 to PsV, and it
further localizes the signals of association with two haplo-
type blocks at non-coding regions. This locus seems to act
independent of PSORS1 at the HLA locus. In order to de-
termine the exact nature of SLC12A8 in the pathogenesis of
psoriasis, however, identification of the disease-causing
variants and functional studies are required.
Methods
Study population PsV patients. For a detailed description of the
sample of 210 trios, we refer to Hensen et al (2003).
The 375 single patients with PsV were of German origin and
were recruited through dermatology clinics at two psoriasis reha-
bilitation hospitals. An early onset form of psoriasis—mainly plaque
type of PsV—was diagnosed in all but three patients, with an av-
erage age of onset of 23  11 y. The medium age at the time of
recruitment was 50  12 y. Sixty-two percent of patients were
male. The study, including recruitment of controls, was approved
by the ethical committee of the University of Mu¨nster.
Controls The 376 controls had no PsV at the time of recruitment,
when the average age was 32  10 y. All of them were healthy
blood donors and were recruited in Northern Germany. Fifty-nine
percent of probands were male.
The individuals gave their written informed consent. The inves-
tigations were conducted according to the Declaration of Helsinki
principles.
Sequencing Seventy-one amplicons extending 44 kb of the gene
SLC12A8 were sequenced in a total of 24 samples (for primer
sequences, see Table S1). Amplicons included the 14 exons of
SLC12A8 from Hewett et al (2002) and another 58, chosen for
equal coverage of the gene and for evolutionary sequence con-
servation. After PCR reactions in an MJ Research thermocycler
(Biozym, Hess Oldendorf, Germany), the PCR products were pu-
rified with the PCR Purification Kit (Qiagen, Hilden, Germany) on a
robotic system (Tecan Miniprep 75-2 with vacuum station, Tecan,
Crailsheim, Germany) with Millipore Montage PCR Cleanup Filter
Plates (Millipore, Schwalbach, Germany). Sequencing reactions
were performed using the Big Dye Terminator Cycle Sequencing
Kit Version 3 or 3.1 (Applied Biosystems, Foster City, California)
according to the manufacturer’s instructions, and were purified on
the same robotic system with the Millipore Montage SEQ Se-
quencing Reaction Cleanup Kit or with the Dye-Ex Purification Kit
(Qiagen). They were analyzed in an ABI Prism Model 3100 or 3730
Sequencer (Applied Biosystems), whereas sequencing analysis
was performed with the software SeqMan II (DNA-Star, Madison,
Wisconsin).
SNP genotyping Genotyping of the 35 tag SNPs was performed
with either Taqman SNP Genotyping Assays from Applied Biosys-
tems or with self-designed primers and TaqMan mgb-probes (for
assay information, see Table S2). All Taqman reactions were pre-
pared from a PCR master mix consisting of 2  Taqman Master-
mix (Eurogentec, Seraing, Belgium) and of 20  or 40  prepared
Genotyping Assay Mix of primers and probes or single primers and
probes. They were carried out in an ABI Prism 7900HT Sequence
Detection System (Applied Biosystems) using standard thermal
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cycling conditions. Hardy–Weinberg equilibrium was tested in the
two samples of single individuals for all SNPs with Finetti (http://
ihg.gsf.de/cgi-bin/hw/hwa1.pl). Taqman genotypes for all poly-
morphisms were verified by direct sequencing of 24 randomly
chosen samples. For stratification to PSORS1, two previously de-
scribed htSNPs in the HCR gene at positions 325 and 2327 that
cover the haplotype diversity within this gene were chosen (As-
umalahti et al, 2003; Huffmeier et al, 2005) and genotyped as de-
scribed previously (Huffmeier et al, 2005).
LD analysis, statistical and haplotype analysis Pairwise LD was
estimated using Ldmax, as implementation of the program GOLD
(graphical overview of LD) (Abecasis and Cookson, 2000). LD
blocks were inferred from the data of the 24 samples sequenced.
The same procedure was used for confirmation of the haplotype
block structure in the groups of 375 PsV patients and of 376 un-
related controls. Haplotypes for the whole sequenced region and in
every haplotype block were calculated with PHASE in the set of 24
probands (Stephens et al, 2001). SNPtagger (Ke and Cardon, 2003)
was used to determine a total of 35 tag SNPs. To test for allelic
association of single SNPs in the trios, we used the family-based
association test (FBAT) (Laird et al, 2000). In the case–control
study, association with single SNPs was tested using a w2-statis-
tics, or in the case of very few expected observations, with Fisher’s
exact test. In a first step we calculated a w2-test based on
the number of alleles in the case–control samples; for alleles yield-
ing a significant p-value (po0.05), we calculated an additional
w2-test based on the number of different genotypes to exclude
that homozygosity for the risk allele falsified our results (Sasieni,
1997). OR and their confidence intervals were determined for
single SNP alleles with final p-values of o0.05.
In the control and patient samples, haplotypes within the blocks
were calculated with PHASE (Stephens et al, 2001) and Haploview
(Barrett et al, 2004).
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